FLT3 and acute myeloid leukemia: One of the most common mutations in AML is internal tandem duplication (ITD) of the juxtamembrane domain of the fms-like tyrosine kinase receptor-3 (FLT3) gene, which renders the encoded protein constitutively active [3].